You are on page 1of 2

MinoxiMed Launches New Website for Africa

Middleton, MA, June 12, 2018 --(PR.com)-- MinoxiMed LLC expand their business in Africa; they
launched a new website for African orders. As a beginning, MinoxiMed hair care products will be
available in Kenya, and soon it will be spread to other African countries.

MinoxiMed is a hair care product for men, intended to increase hair growth all over the scalp and beard.
For easier use, it is manufactured in liquid form. 15 drops of the product should be rubbed into the roots
of the hair or beard every morning and every night. It normalizes the function of the follicles and the hair
structure by neutralizing the harmful effects of the environment and shampoos. MinoxiMed also
nourishes and strengthens hair roots, and restores weak and damaged hair.

Four herbs are included in MinoxiMed's composition.

Urtica dioica, used for decades as an herbal remedy, is known for its ability to relieve the pain in muscles
and joints. When applied externally, this ingredient strengthens the hair follicle, stops hair fall, and
stimulates hair growth.

Panax ginseng combats hair loss and promotes hair growth in both men and women.

Tussilago farfara is usually used for treating dandruff. Its anti-bacterial properties make the herb
anti-septic for all types of external wounds. Tussilago farfara contains minerals and plant proteins which
all work together to help hair recovery, improve elasticity, and stimulate hair growth.

Achillea millefolium is usually used for treating itching, scalp irritation, dandruff, and oily scalp. It has
also been used to combat hair loss.

Comprehensive information about MinoxiMed way of use, current prices and promotions can be found on
product's official website minoximedhair.com

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
MinoxiMed LLC
Simon Legrand
+442036950239
Contact via Email
www.minoximed.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/756294

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use

You might also like